All Stories

  1. Correlating clinical course with baseline subcortical shape in provisional tic disorder
  2. Diagnostic Criteria for Primary Tic Disorders: More Reappraisal
  3. Tourette syndrome research highlights from 2023
  4. What's new with tics and Tourette's? Highlights from 2023.
  5. Tics that started recently usually get better but almost never go away completely.
  6. Tics in ADHD
  7. Tourette syndrome research highlights from 2022
  8. Door-To-Door Video-Enhanced Prevalence Study of Tourette Disorder Among African Americans
  9. Smoke gets in your tics
  10. Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders
  11. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
  12. Early‐Life and Family Risk Factors for Tic Disorder Persistence into Adulthood
  13. Tics in ADHD
  14. Finding reviewer suggestions for multi-author papers
  15. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  16. Editorial: Recent advances in understanding Tourette syndrome, tic disorders and functional tics
  17. Smoke gets in your tics
  18. Will people buzz their wrist in their daily life to help their tics?
  19. Testing whether median nerve stimulation helps tics by the mechanism we thought it did
  20. Tics in ADHD
  21. Suggestions for new NIH grant applicants
  22. Peripheral nerve induction of inhibitory brain circuits to treat Tourette syndrome: A randomized crossover trial
  23. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  24. TikTok Tourette’s: Are We Witnessing a Rise in Functional Tic-Like Behavior Driven by Adolescent Social Media Use?
  25. Tic prevalence by direct observation in an elementary school
  26. Tourette syndrome research highlights from 2021
  27. Diagnosis and Management of Functional Tic-Like Phenomena
  28. Door-to-door Video-Enhanced Prevalence Study of Tourette Disorder Among African Americans
  29. Why Tic Severity Changes from Then to Now and from Here to There
  30. 3.122 Open Trial of Median Nerve Stimulation for the Treatment of Tourette’s Disorder
  31. 13.2 Predictors of Tic Symptom Evolution After First Onset
  32. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  33. Median nerve stimulation for treatment of tics: A 4-week, open trial with ecological momentary assessment
  34. TikTok Tourette's: are we witnessing a rise in neurological conditions driven by adolescent social media use?
  35. Why tic severity changes from then to now and from here to there
  36. The start of the biggest brain imaging and genetics study ever in Tourette syndrome
  37. Finding reviewer suggestions for multi-author papers
  38. Optimal timing for lithium levels
  39. Tourette syndrome research highlights from 2021
  40. Tourette syndrome research highlights from 2020
  41. Neurobiology and Functional Anatomy of Tic Disorders
  42. The timing of tics is fractal, even in the first few months of a tic disorder
  43. Tourette syndrome research highlights from 2020
  44. Treatment failure in persistent tic disorders: an expert clinicians’ consensus-based definition
  45. Predicting Clinical Course from Subcortical Shape in Provisional Tic Disorder
  46. Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target Engagement
  47. Recent progress on Tourette syndrome
  48. A Comprehensive Review of Tic Disorders in Children
  49. What happens to tic disorders over time?
  50. "I can hold my tics back for a while. What does that tell me?"
  51. TicTimer Web: software for measuring tic suppression remotely
  52. Electronic medical records need to accommodate confidentiality for presymptomatic testing
  53. The Child with Tics or Other Common Movement Disorders
  54. Tourette syndrome research highlights from 2019
  55. Course of tic disorders over the lifespan
  56. Tourette syndrome research highlights from 2019
  57. TicTimer Web: software for measuring tic suppression remotely
  58. Correlates and clinical implications of tic suppressibility
  59. Size of hippocampus predicts improvement in children with recent-onset tics
  60. Phonic tics and one motor tic? Call it Tourette syndrome.
  61. Can we measure Parkinson disease severity with levodopa and MRI?
  62. Age-dependent differences in functional brain networks are atypical in Tourette syndrome
  63. In obesity, pictures of high-calorie food elicit dopamine release equally when hungry or full.
  64. Hippocampal volume in Provisional Tic Disorder predicts tic severity at 12-month follow-up
  65. What happens to children with recent-onset tics, and why?
  66. Dopamine buffering capacity imaging: A pharmacodynamic fMRI method for staging Parkinson disease
  67. 2.54 EXPLORING BEHAVIORAL MARKERS PREDICTING ONE-YEAR TIC OUTCOME IN CHILDREN WITH RECENT-ONSET TICS
  68. Treating depression in epilepsy: a controlled trial
  69. The urge to blink in Tourette syndrome
  70. Tourette syndrome research highlights from 2018
  71. Atypical Functional Connectivity In Tourette Syndrome differs between Children and Adults
  72. Tic Suppression in Children With Recent-Onset Tics Predicts 1-Year Tic Outcome
  73. In Provisional Tic Disorder, better tic suppression predicts better prognosis
  74. Provisional Tic Disorder is not so transient
  75. Correction: Brain structure in pediatric Tourette syndrome
  76. Ziprasidone may have a role in treating psychosis in Parkinsonian disease
  77. The urge to blink in Tourette syndrome
  78. How to switch to pimavanserin from an older antipsychotic for psychosis in Parkinson's disease
  79. Atypical Functional Connectivity in Tourette Syndrome Differs Between Children and Adults
  80. Transient tics aren't: Outcome of recent-onset tic disorder at one year
  81. Testing a new (D1) dopamine blocking strategy to treat Tourette syndrome in children
  82. TicTrainer software
  83. Research on tic disorders from 2017
  84. Effects of DBS in dorsal vs. ventral STN
  85. Who can suppress tics best?
  86. Tourette Syndrome
  87. TicTimer software for measuring tic suppression
  88. TicTrainer web software for tic suppression training
  89. Tourette syndrome research highlights from 2016
  90. Patterns and predictors of tic suppressibility in youth with tic disorders
  91. 4.36 A Randomized, Double-Blind, Placebo-Controlled Study of the D1 Receptor Antagonist Ecopipam for Children and Adolescents With Tourette's Disorder
  92. TicTimer: software for measuring tic suppression
  93. Tourette syndrome research highlights from 2016
  94. Mapping movement, mood, motivation, and mentation in the subthalamic nucleus
  95. A Case of Apparent Upper-Body Freezing in Parkinsonism while Using a Wheelchair
  96. What creates the urge to tic in Tourette syndrome?
  97. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia
  98. Brain structure in pediatric Tourette syndrome
  99. VISIT-TS: A multimedia tool for population studies on tic disorders
  100. A picture is worth 1000 words: a new tool for Tourette studies
  101. Tourette syndrome research highlights 2015
  102. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status
  103. Sweet Dopamine: Sucrose Preferences Relate Differentially to Striatal D 2 Receptor Binding and Age in Obesity
  104. Brain structure in pediatric Tourette syndrome
  105. When do tics turn into Tourette syndrome?
  106. Return of QuanDyn(TM)
  107. Designing MRI studies of children with neuropsychiatric disorders
  108. Machine learning "diagnosis" of Tourette syndrome by resting brain activity
  109. Correction: Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
  110. Safety of i.v. L-DOPA
  111. Automated training to hold still
  112. A review session can raise medical student scores on the psychiatry shelf exam
  113. Impact of a structured review session on medical student psychiatry subject examination performance
  114. Stand up for i.v. levodopa!
  115. Brain imaging in Tourette's, 2014-2015
  116. Safety of i.v. L-DOPA (preprint)
  117. Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
  118. Tourette Syndrome research highlights 2014
  119. Brain dopamine pathways influence emotional eating
  120. Rapid quantitative pharmacodynamic imaging with Bayesian estimation
  121. Whole-brain blood flow correction in ASL
  122. Tourette Syndrome research highlights 2014
  123. Kids can suppress tics early on--if the price is right
  124. Levodopa effects on [11C]raclopride binding in the resting human brain
  125. Tics
  126. Arterial spin labeling versus BOLD in direct challenge and drug-task interaction pharmacological fMRI
  127. F1000Research: Tics welcomes you to 21st century biomedical publishing
  128. Intro to special issue on Tourette syndrome
  129. Current anxiety disorder affects mood response to STN DBS in PD
  130. A revised method for measuring distraction by tactile stimulation
  131. Anatomical location in STN matters for DBS in Parkinson's
  132. Insulin, dopamine D2 receptors, and monetary reward discounting: A common pathway for food and drug addiction
  133. Developmental Changes in the Organization of Functional Connections between the Basal Ganglia and Cerebral Cortex
  134. Spatial Reorganization of Putaminal Dopamine D2-Like Receptors in Cranial and Hand Dystonia
  135. Levodopa-stimulated dopamine release in Tourette syndrome
  136. A within-subject comparison of seizure duration with etomidate and methohexital in electroconvulsive therapy
  137. Prolactin and fMRI response to SKF38393 in the baboon
  138. Automatic size and shape measurements of deep brain structures in Tourette syndrome
  139. Rapid quantitative pharmacodynamic imaging by a novel method: theory, simulation testing and proof of principle
  140. Towards objectively quantifying sensory hypersensitivity: a pilot study of the “Ariana effect”
  141. Olanzapine for psychosis in Parkinson disease
  142. Neurobiology and Functional Anatomy of Tic Disorders
  143. A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with (N‐[11C]methyl)benperidol
  144. NMB PET outside the striatum
  145. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
  146. Mood Response to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
  147. Prospectively Determined Impact of Type 1 Diabetes on Brain Volume During Development
  148. A New (Old) Treatment Option for Depression in Parkinson's Disease
  149. Clinical Vignettes in Parkinson's Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive Behaviours
  150. Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol) (TSfMRI)
  151. A Perfusion MRI Study of Emotional Valence and Arousal in Parkinson’s Disease
  152. Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease
  153. Tics
  154. Deep brain stimulation for Tourette syndrome
  155. Hippocampal Volumes in Youth With Type 1 Diabetes
  156. Neuroimaging in Baboons
  157. Cerebral Mitochondrial Metabolism in Early Parkinson's Disease
  158. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease
  159. Psychiatric screening for DBS
  160. The Cognitive Correlates of Functional Status: A Review From the Committee on Research of the American Neuropsychiatric Association
  161. Regional Brain Volume Differences Associated With Hyperglycemia and Severe Hypoglycemia in Youth With Type 1 Diabetes
  162. Validity of large-deformation high dimensional brain mapping of the basal ganglia in adults with Tourette syndrome
  163. Intravenous levodopa administration in humans based on a two-compartment kinetic model
  164. The Value of Quantitative Electroencephalography in Clinical Psychiatry: A Report by the Committee on Research of the American Neuropsychiatric Association
  165. Repetitive and impulsive behaviors in treated Parkinson disease
  166. II.P5 Effects of Parkinson Disease (PD) laterality on spatial working memory performance
  167. Sex, Lies, and Neuroimaging
  168. Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group
  169. Brain Stimulation in Psychiatric Treatment
  170. Blood Flow Imaging of the Brain: 50 Years Experience
  171. Levodopa Challenge Neuroimaging of Levodopa-Related Mood Fluctuations in Parkinson's Disease
  172. Pathophysiology of parkinsonism due to hydrocephalus
  173. Dopaminergic modulation of response inhibition: an fMRI study
  174. Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study
  175. Atlas Template Images for Nonhuman Primate Neuroimaging: Baboon and Macaque
  176. Asymmetric regional cerebral blood flow in sedated baboons measured by positron emission tomography (PET)
  177. Rapid intravenous loading of levodopa for human research: clinical results
  178. Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease
  179. A possible substrate for dopamine-related changes in mood and behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist
  180. Psychiatric Neuroimaging Research
  181. Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
  182. Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
  183. Template Images for Nonhuman Primate Neuroimaging: 2. Macaque
  184. Template Images for Nonhuman Primate Neuroimaging: 1. Baboon
  185. Dopa-Induced Blood Flow Responses in Nonhuman Primates
  186. Response to levodopa challenge in Tourette syndrome
  187. Neuropsychiatry of movement disorders
  188. On the efficiency of stereologic volumetry as commonly implemented for three-dimensional digital images
  189. Diminished regional cerebral blood flow response to vibration in patients with blepharospasm
  190. Altered thalamic response to levodopa in Parkinson’s patients with dopa-induced dyskinesias
  191. Putamen volume in idiopathic focal dystonia
  192. Preventing contractures in NMS and dystonia
  193. MPTP induces dystonia and parkinsonism
  194. Baboon Basal Ganglia Stereotaxy Using Internal MRI Landmarks: Validation and Application to PET Imaging
  195. Personality disorder scores improve with effective pharmacotherapy of depression
  196. Stereological MRI volumetry of the frontal lobe
  197. A Metric for Testing the Accuracy of Cross-Modality Image Registration: Validation and Application
  198. The Dexamethasone Suppression Test for Diagnosing Depression in Stroke Patients
  199. Anosognosia for Depressive Signs
  200. Diagnosing Depression After Stroke
  201. Platelet Binding Characteristics Distinguish Placebo Responders from Nonresponders in Depression
  202. MRI volumetry of prefrontal cortex
  203. Hippocampal MR volumetry
  204. Severe Imipramine-Induced Myoclonus in a Patient with Psychotic Bipolar Depression, Catatonia, and Schizencephaly
  205. Subcortical brain anatomy in anorexia and bulimia
  206. Faculty of 1000 evaluation for Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome.
  207. TicTimer software for measuring tic suppression
  208. “But my department chair wants big-name journals”: Gentle steps to open publishing
  209. Software for web-based tic suppression training
  210. Tics
  211. Treatment of Parkinson’s disease psychosis
  212. Tourette syndrome research highlights from 2016
  213. BillCorrectly: A software tool to help psychiatrists bill E&M codes appropriately
  214. Suggestions for new NIH grant applicants